The object of this proposal is to elucidate the mechanisms for the earliest stages of gene induction in activated or differentiating monocytes. The primary focus will be on gene regulation, paying particular attention to inducible transcription factors responsible for mediating differentiation and cell activation. The approach is to use prointerleukin 1-beta (IL1B) and a small number of other inducible monocyte-specific genes as examples for investigating the mechanisms of immediate early gene induction in monocytes. Evaluation of transiently transfected portions of these genes will be studied along with the binding of specific protein factors in order to gain insight into the regulatory mechanisms. The cDNA sequences for several transcription factors which appear to be important for monocyte activation and differentiation will be used in cotransfection studies aimed at overexpression in order to evaluate specific effects. Similarly, dominant-negative mutants of these factors will also be investigated.
Specific Aims are: (I) to elucidate the functional mechanism of action for the IL1B Upstream Induction Sequence (UIS) which targets cell type-independent induction of the IL1B gene; (2) to examine the function of the tissue-restricted Spi-I/PU.I transcription factor, which binds to the promoter proximal sequence in the IL1B gene and other monocyte-specific genes to confer tissue-specific expression. Our previous studies demonstrated that human cytomegalovirus (HCMV) IE1 protein trans-activation of the IL1B gene requires an intact Spi-I/PU.I binding site. Therefore, the relationship between Spi-I/PU.I and HCMV IE1 will be investigated using these two proteins in functional and structural studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA068544-05
Application #
2763400
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Finerty, John F
Project Start
1995-08-25
Project End
2000-05-31
Budget Start
1998-09-30
Budget End
1999-05-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Pulugulla, Sree H; Workman, Riley; Rutter, Nathan W et al. (2018) A combined computational and experimental approach reveals the structure of a C/EBP?-Spi1 interaction required for IL1B gene transcription. J Biol Chem 293:19942-19956
Listman, James A; Race, JoAnne E; Walker-Kopp, Nancy et al. (2008) Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator. Mol Immunol 45:2667-77
Unlu, Sebnem; Kumar, Arvind; Waterman, Wayne R et al. (2007) Phosphorylation of IRF8 in a pre-associated complex with Spi-1/PU.1 and non-phosphorylated Stat1 is critical for LPS induction of the IL1B gene. Mol Immunol 44:3364-79
Wang, Kent Z Q; Wara-Aswapati, Nawarat; Boch, Jason A et al. (2006) TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src. J Cell Sci 119:1579-91
Waterman, Wayne R; Xu, Li Lian; Tetradis, Sotirios et al. (2006) Glucocorticoid inhibits the human pro-interleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer. Mol Immunol 43:773-82
Listman, James A; Wara-aswapati, Nawarat; Race, JoAnne E et al. (2005) Conserved ETS domain arginines mediate DNA binding, nuclear localization, and a novel mode of bZIP interaction. J Biol Chem 280:41421-8
Yoshida, Yasuhiro; Kumar, Arvind; Koyama, Yoshinobu et al. (2004) Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J Biol Chem 279:1768-76
Boch, Jason A; Yoshida, Yasuhiro; Koyama, Yoshinobu et al. (2003) Characterization of a cascade of protein interactions initiated at the IL-1 receptor. Biochem Biophys Res Commun 303:525-31
Tan, Lujian; Peng, Haibing; Osaki, Makoto et al. (2003) Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 278:17688-700
Osaki, Makoto; Tan, Lujian; Choy, Bob K et al. (2003) The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2. Biochem J 369:103-15

Showing the most recent 10 out of 20 publications